The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

Key Takeaways A modified DASH diet for T2D, combined with sodium reduction, significantly lowers blood pressure, even in patients on multiple antihypertensive medications.

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension.

Treating coronary artery disease will involve a personalised treatment plan consisting of lifestyle changes and a combination of medications. Learn more here.

Lorundrostat treatment led to greater reductions in 24-hour mean blood pressure compared with placebo in trial participants with uncontrolled and treatment-resistant hypertension.

The US Food and Drug Administration will no longer require aprocitentan (Tryvio), a novel endothelin receptor antagonist, to be part of its drug safety program, according to an announcement from ...

Mineralys Therapeutics enjoyed a 45% stock bump after its aldosterone synthase inhibitor chalked up wins in two types of hypertension.

Topline data were announced from a phase 3 trial investigating lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension.

Adults receiving semaglutide for the treatment of obesity were more likely to have antihypertensive or lipid-lowering therapy tapered or discontinued than those receiving placebo, according to ...

Deprescribing antihypertensive medications is associated with reduced cognitive decline among older residents of nursing homes, particularly those with dementia.

It does not matter whether antihypertensive medication is taken in the morning or at bedtime, two new trials confirm.